When should antiretroviral therapy for HIV be started?

Treatments for HIV have advanced rapidly over the past decade. Andrew Phillips and colleagues argue that we should re-evaluate the timing of treatment in the light of new knowledge

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BMJ 2007-01, Vol.334 (7584), p.76-78
Hauptverfasser:	Phillips, Andrew N, Gazzard, Brian G, Clumeck, Nathan, Losso, Marcelo H, Lundgren, Jens D
Format:	Artikel
Sprache:	eng
Schlagworte:	Acquired immune deficiency syndrome Acquired Immunodeficiency Syndrome - prevention & control AIDS Analysis Analysis and Comment Antiretroviral drugs Antiretroviral therapy Antiretroviral Therapy, Highly Active Antiretrovirals Antivirals Biological and medical sciences CD4 Lymphocyte Count Disease risk Epidemiology General aspects HIV HIV 1 HIV infections HIV Infections - drug therapy Human immunodeficiency virus Human viral diseases Humans Immunodeficiencies Immunodeficiencies. Immunoglobulinopathies Immunopathology Infectious diseases Medical sciences Medical treatment Myocardial infarction Risk Factors Time Timing Viral diseases Viral diseases of the lymphoid tissue and the blood. Aids Viral load
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Treatments for HIV have advanced rapidly over the past decade. Andrew Phillips and colleagues argue that we should re-evaluate the timing of treatment in the light of new knowledge
ISSN:	0959-8138 0959-8146 0959-535X 1468-5833 1756-1833
DOI:	10.1136/bmj.39064.406389.94